Early research (Phase 1)Study completedNCT01848002
What this trial is testing
Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers
Who this might be right for
Congenital Bleeding DisorderCongenital FXIII DeficiencyHealthy
Novo Nordisk A/S 24